99 related articles for article (PubMed ID: 27780606)
1. Paranuclear dot-like pancytokeratin positivity and MLH1/PMS2 loss in large cell neuroendocrine carcinoma of the endometrium.
Chougule A; Garg R; Jain V
Pathology; 2016 Dec; 48(7):736-739. PubMed ID: 27780606
[No Abstract] [Full Text] [Related]
2. Colorectal large-cell neuroendocrine carcinoma with lymphoid stroma: further evidence confirming a unique subtype associated with MLH1/PMS2 loss, BRAF mutation, Epstein-Barr virus negativity, and the possibility of a better prognosis.
Chetty R; Capo-Chichi JM; Serra S
Histopathology; 2019 Aug; 75(2):247-253. PubMed ID: 30990915
[TBL] [Abstract][Full Text] [Related]
3. Interpretation of Mismatch Repair Protein Immunohistochemistry in Endometrial Carcinoma Should Consider Both Lynch Syndrome Screening and Immunotherapy Susceptibility: An Illustrative Case Report.
Chapel DB; Lengyel E; Ritterhouse LL; Lastra RR
Int J Gynecol Pathol; 2020 May; 39(3):233-237. PubMed ID: 30807370
[TBL] [Abstract][Full Text] [Related]
4. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM
Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759
[TBL] [Abstract][Full Text] [Related]
5. Abrupt loss of MLH1 and PMS2 expression in endometrial carcinoma: molecular and morphologic analysis of 6 cases.
Pai RK; Plesec TP; Abdul-Karim FW; Yang B; Marquard J; Shadrach B; Roma AR
Am J Surg Pathol; 2015 Jul; 39(7):993-9. PubMed ID: 25786082
[TBL] [Abstract][Full Text] [Related]
6. Combined large cell neuroendocrine and endometrioid carcinoma of the endometrium.
Mulvany NJ; Allen DG
Int J Gynecol Pathol; 2008 Jan; 27(1):49-57. PubMed ID: 18156975
[TBL] [Abstract][Full Text] [Related]
7. Role of endometrial cancer abnormal MMR protein in screening Lynch-syndrome families.
Long Q; Peng Y; Tang Z; Wu C
Int J Clin Exp Pathol; 2014; 7(10):7297-303. PubMed ID: 25400828
[TBL] [Abstract][Full Text] [Related]
8. Mismatch repair proteins and microsatellite instability in solid pseudopapillary neoplasm of the pancreas.
Covelli C; Parente P; Pepe F; Pisapia P; Fiordelisi F; Malapelle U
Hepatobiliary Pancreat Dis Int; 2019 Oct; 18(5):491-492. PubMed ID: 31477525
[No Abstract] [Full Text] [Related]
9. Does Strong and Diffuse PAX-8 Positivity Occur in Primary Lung Carcinoma? An Immunohistochemical Study of 418 Cases and Review of the Literature.
McHugh KE; Arrossi AV; Farver CF; Mukhopadhyay S
Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):140-146. PubMed ID: 28777151
[TBL] [Abstract][Full Text] [Related]
10. Combined large-cell neuroendocrine carcinoma and endometrioid adenocarcinoma of the endometrium: A case report and survey of related literature.
Matsumoto H; Nasu K; Kai K; Nishida M; Narahara H; Nishida H
J Obstet Gynaecol Res; 2016 Feb; 42(2):206-10. PubMed ID: 26807962
[TBL] [Abstract][Full Text] [Related]
11. SWI/SNF complex deficiency and mismatch repair protein expression in undifferentiated and dedifferentiated endometrial carcinoma.
Stewart CJ; Crook ML
Pathology; 2015 Aug; 47(5):439-45. PubMed ID: 26126041
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine Carcinoma of the Endometrium: A Clinicopathologic Study of 25 Cases.
Pocrnich CE; Ramalingam P; Euscher ED; Malpica A
Am J Surg Pathol; 2016 May; 40(5):577-86. PubMed ID: 26945341
[TBL] [Abstract][Full Text] [Related]
13. [Expression of MMR in endometrial adenocarcinoma in women under 50 years old].
Wu HX; Song JC; Shi YQ; Liu YX
Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):733-6. PubMed ID: 23302332
[TBL] [Abstract][Full Text] [Related]
14. Mismatch Repair Protein Expression in Clear Cell Carcinoma of the Ovary: Incidence and Morphologic Associations in 109 Cases.
Bennett JA; Morales-Oyarvide V; Campbell S; Longacre TA; Oliva E
Am J Surg Pathol; 2016 May; 40(5):656-63. PubMed ID: 26813747
[TBL] [Abstract][Full Text] [Related]
15. Importance of universal mismatch repair protein immunohistochemistry in patients with sebaceous neoplasia as an initial screening tool for Muir-Torre syndrome.
Jessup CJ; Redston M; Tilton E; Reimann JD
Hum Pathol; 2016 Mar; 49():1-9. PubMed ID: 26826402
[TBL] [Abstract][Full Text] [Related]
16. Large cell neuroendocrine carcinoma of the uterine cervix exhibiting TTF1 immunoreactivity.
McCluggage WG; Sargent A; Bailey A; Wilson GE
Histopathology; 2007 Sep; 51(3):405-7. PubMed ID: 17727482
[No Abstract] [Full Text] [Related]
17. Two versus four immunostains for Lynch syndrome screening in endometrial carcinoma.
Niu BT; Hammond RFL; Leen SLS; Gilks CB; Singh N
Histopathology; 2019 Sep; 75(3):442-445. PubMed ID: 31077605
[No Abstract] [Full Text] [Related]
18. Contributions by MutL homologues Mlh3 and Pms2 to DNA mismatch repair and tumor suppression in the mouse.
Chen PC; Dudley S; Hagen W; Dizon D; Paxton L; Reichow D; Yoon SR; Yang K; Arnheim N; Liskay RM; Lipkin SM
Cancer Res; 2005 Oct; 65(19):8662-70. PubMed ID: 16204034
[TBL] [Abstract][Full Text] [Related]
19. Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas.
McConechy MK; Talhouk A; Li-Chang HH; Leung S; Huntsman DG; Gilks CB; McAlpine JN
Gynecol Oncol; 2015 May; 137(2):306-10. PubMed ID: 25636458
[TBL] [Abstract][Full Text] [Related]
20. Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation.
Gill S; Lindor NM; Burgart LJ; Smalley R; Leontovich O; French AJ; Goldberg RM; Sargent DJ; Jass JR; Hopper JL; Jenkins MA; Young J; Barker MA; Walsh MD; Ruszkiewicz AR; Thibodeau SN
Clin Cancer Res; 2005 Sep; 11(18):6466-71. PubMed ID: 16166421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
